TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 11.04
0.00 (0.00%)
Apr 17, 2026, 4:08 PM HKT
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 4.25 billion as of April 17, 2026. Its market cap has decreased by -59.53% in one year.
Market Cap
4.25B
Enterprise Value
4.01B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
11.04
Market Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 4.25B, a decrease of -16.41%. That is a compound annual growth rate of -10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 4.25B | -14.77% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qyuns Therapeutics | 4.71B |
| Shandong Boan Biotechnology | 4.52B |
| Beijing Luzhu Biotechnology | 4.48B |
| Antengene Corporation | 4.08B |
| Viva Biotech Holdings | 4.05B |
| Clover Biopharmaceuticals | 3.79B |
| BioDlink International Company | 3.78B |
| Mirxes Holding Company | 3.66B |